FCAM
REGN icon

F&C Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

F&C Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$6.32M Buy
21,037
+526
+3% +$162K 0.08% 290
2013
Q4 		$5.64M Buy
20,511
+510
+3% +$147K 0.07% 316
2013
Q3 		$6.26M Buy
20,001
+411
+2% +$108K 0.08% 294
2013
Q2 		$4.41M Buy
+19,590
New +$4.56M 0.06% 342

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

F&C Asset Management's REGN Position: Q1 2014 in Review

F&C Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 2.6% in Q1 2014, buying an estimated $162K and bringing the position to 21,037 shares worth $6.32M. The position accounts for 0.08% of the portfolio, ranked #290.

F&C Asset Management first reported a position in REGN in Q2 2013 and has held it in 4 quarters since. 452 funds tracked by Wall St. Rank hold REGN as of Q1 2014.

  • F&C Asset Management held 21,037 shares of Regeneron Pharmaceuticals worth $6.32M as of Q1 2014.
  • F&C Asset Management bought 526 Regeneron Pharmaceuticals shares in Q1 2014, an estimated $162K.
  • Regeneron Pharmaceuticals made up 0.08% of F&C Asset Management's portfolio in Q1 2014, its #290 holding.
  • F&C Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 4 quarters since.
  • 452 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2014.

Based on F&C Asset Management's 13F filing for Q1 2014, filed 14 May 2014.